共 5 条
- [2] Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong.[J].Peter W.H. Lee;Tracy T.C. Kwan;Kar Fai Tam;Karen K.L. Chan;Phyllis M.C. Young;Sue S.T. Lo;Annie N.Y. Cheung;Hextan Y.S. Ngan.Preventive Medicine.2007, 2
- [3] Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.[J].Diane M Harper;Eduardo L Franco;Cosette M Wheeler;Anna-Barbara Moscicki;Barbara Romanowski;Cecilia M Roteli-Martins;David Jenkins;Anne Schuind;Sue Ann Costa Clemens;Gary Dubin.The Lancet.2006, 9518
- [4] Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.[J].Eduardo L. Franco;Diane M. Harper.Vaccine.2005, 17
- [5] 中国部分市县恶性肿瘤的发病与死亡.[M].李连弟; 主编.人民卫生出版社.2007,